Meet our Chief Science Officer

  • PhD, Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia, 2010
  • Postdoctoral, Bioengineering, Georgia Institute of Technology, Atlanta, Georgia, 2010 – 2013


Honors and Awards

  • Gandy Diaz Teaching Fellowship – Georgia Institute of Technology, Spring 2014
  • F32 Ruth L. Kirschstein National Research Service Award Postdoctoral Fellowship – National Institute of Health, 2011-2013
  • Young Investigator Award – American Society for Bone and Mineral Research, July 2012
  • Travel Award – Hilton Head Workshop on Regenerative Medicine, March 2011
  • First Place in the PhD Podium Presentation Competition – American Society of Mechanical Engineering Summer Bioengineering Conference, 2005-2009
  • Predoctoral Fellowship – American Heart Association Southeast Division, 2007-2009
  • Best Presentation at the Frontiers in Graduate Pharmacology Research Symposium – Emory University, May 2008
  • Best Oral Presentation, Principles of Excellence in Nanotechnology Conference – University of California Santa Barbara, October 2007
  • Honorable Mention in the Discovery Learning Center Research Symposium – University of Colorado, December 2004
  • First Place in the Discovery Learning Research Symposium – University of Colorado, May 2004
  • Giroux Engineering Scholarship – University of Colorado, 2002-2003

Research Focus

  • Tissue level systems integration for musculoskeletal disease and regenerative engineering.


Current Research

    • 2012-2014 – (role: Coauthor) “IL-1Ra-Tethered Nanoparticles to Treat Joint Inflammation and OA,” Innovative Research Grant, Arthritis Foundation
    • 2013 – (role: Co-Investigator) “Biomechanics and Biocompataibility of Porous Poly(para-phenylenes) Scaffolds,” Contract Work for Prof. CM Yakacki, University of Colorado
    • 2014-2017 – (role: Co-investigator) “Collaborative Research: Integration of Implantable MEMS Sensors and Computational Modeling to Assess Mechanical Regulation of Bone Regeneration.” National Science Foundation
    • 2014-2015 – (role: PI) “An Early Warning System for Non-Union of Pediatric Bone Fusion Devices.” Center for Pediatric Innovation, Emory + Children’s Pediatric Research Center

Completed Research

  • 2011-2013 – (role: PI) “Limb Restoration Using a Novel Rat Model of Composite Bone and Muscle Injury,” National Institute of Health, NRSA F32 Fellowship – 1F32AR061236-01
  • 2007-2009 – (role: PI) “Shear Stress Induced Expression of Inflammatory Cell Adhesion Molecules in a Mouse Coarctation Model,” American Heart Association, Predoctoral Fellowship


FDA logo

Stem cell science is an innovative treatment approach that involves utilizing stem cells to stimulate the body’s natural repair response.

Contrary to popular belief, stem cell science does not involve the use of fetal or embryonic stem cells, but rather the use of stem cells derived from fat, bone marrow, cord blood and other sources. While there are many stem cell sources, not all stem cells are equal. In fact, stem cells derived from umbilical cord blood have the greatest ability to regenerate new tissue with little to no risk of rejection. These younger cells are far more powerful than the stem cells derived from fat and bone marrow, and they don’t require a donor match as is the case with many other types of stem cells.

In many instances, stem cell science is used to promote tissue healing and recovery for orthopedic patients, and for these patients in particular, the use of high quality, cord blood stem cells is vital to their speedy recovery.